Date clarification: Church & Dwight’s Q2 earnings call is scheduled for today, Friday, July 31, 2026, at 10:00 a.m. ET, rather than tomorrow.
The central question is not whether Church & Dwight can beat its deliberately conservative Q2 EPS target. It is whether the report supports the more important second-half thesis: volume-led organic growth, continued gross-margin recovery, and an acceleration in earnings as first-half acquisition and marketing costs moderate.
Management guided Q2 adjusted EPS to $0.88, while market estimates cluster around $0.90–$0.91. Revenue expectations range from approximately $1.50 billion to $1.52 billion. CHD itself expects organic sales growth of about 3%, reported sales down approximately 1%, and gross-margin expansion of roughly 50 basis points. (investor.churchdwight.com)
The stock enters the report near $97.70, roughly:
That valuation leaves room for a modest beat, but probably requires strong forward commentary for meaningful upside.
| Metric | Q2 2026 reference point | Q2 2025 actual | Investor interpretation |
|---|---|---|---|
| Revenue | Street: approximately $1.50B–$1.52B | $1.506B | Reported growth remains distorted by 2025 portfolio exits |
| Reported sales growth | Company: approximately -1% | -0.3% | Organic growth is more informative |
| Organic sales growth | Company: approximately +3% | +0.1% | The most important top-line KPI |
| Adjusted gross margin | Company: approximately +50 bps YoY | — | Tests productivity against transport and commodity inflation |
| Adjusted EPS | Company: $0.88; Street: $0.90–$0.91 | $0.94 | Consensus implies a modest YoY decline |
| Adjusted tax rate | Approximately 21% | — | Secondary earnings variable |
Street estimates imply roughly flat reported revenue and a mid-single-digit decline in adjusted EPS from last year, reflecting higher marketing, TOUCHLAND-related SG&A and amortization, and other first-half investments. (investor.churchdwight.com)
Q1 organic sales increased 5%, including 5.3% volume growth, but management said approximately two percentage points of that performance came from lapping retailer inventory reductions in early 2025. The more normalized underlying result was therefore closer to 3%.
Q2 should provide a cleaner test of the business. Management previously highlighted:
A result around 3% would validate the annual plan. Organic growth materially above 3%, particularly if driven by volume rather than promotional pricing, would strengthen the case for performance near the upper end of full-year guidance.
Watch the composition:
Q1 adjusted gross margin expanded 130 basis points to 46.4%, ahead of expectations. Management’s Q2 outlook calls for a smaller expansion of approximately 50 basis points because transportation pressure was expected to precede mitigation measures.
The Q1 margin bridge included substantial benefits from productivity, acquisitions, portfolio actions and volume, offset by inflation and tariff costs. Management also identified an additional $25 million–$30 million of full-year commodity and transportation pressure associated with higher oil-linked inputs, including diesel, resins and surfactants.
Management’s stated plan was to offset that incremental pressure primarily through accelerated productivity—not broad pricing. That makes the Q2 margin result and second-half margin guidance especially important.
Positive signals would include:
Warning signs would include:
TOUCHLAND remains an important point of debate. In Q1, management said total consumption—including less-visible channels—was up approximately 12%–13%, although tracked-channel data appeared considerably weaker. Holiday multipack timing, club sales and difficult launch comparisons complicated the reported trends.
Management continued to expect double-digit full-year growth, supported by:
Investors should listen for:
A weak quarter could revive concerns that CHD bought the brand near a peak in hand-sanitizer momentum. Sustained double-digit growth would materially reduce that risk.
The strongest Q1 contributors were:
The report should reveal whether THERABREATH and HERO are continuing to scale without excessive marketing support. Investors should also monitor WATERPIK, where Q1 organic performance remained soft.
ARM & HAMMER’s value positioning is especially relevant. Management has argued that financially pressured consumers are increasingly receptive to lower-priced laundry products, while CHD has gained share despite using less promotion than several competitors. Confirmation of this dynamic would support both volume and margin durability.
Current 2026 guidance is:
| Metric | 2026 guidance |
|---|---|
| Reported sales growth | -1.5% to -0.5% |
| Organic sales growth | +3% to +4% |
| Adjusted gross-margin change | Approximately +100 bps |
| Adjusted EPS growth | +5% to +8% |
| Adjusted EPS | $3.71–$3.81 |
| Cash from operations | Approximately $1.15B |
| Capital expenditures | Approximately $130M |
Management has repeatedly said earnings growth should be weighted toward the second half because the first half absorbs heavier marketing, TOUCHLAND SG&A and amortization, and ERP-related costs. (investor.churchdwight.com)
A simple reiteration would be acceptable, but investors will want evidence behind it. In particular:
Given that Q1 exceeded expectations without prompting a guidance increase, a good Q2 could create room for management to narrow or raise the outlook. Conversely, maintaining the range while sounding more cautious about margins could be interpreted as an effective reduction in expectations.
This outcome would validate CHD’s portfolio restructuring and support its premium valuation.
This would be a solid operational result, although the share-price response could be limited without a guidance increase.
Because the shares trade around 26 times the midpoint of guidance, a margin or guidance disappointment could produce a disproportionate negative reaction.
CHD enters Q2 with a favorable operating narrative but a reasonably demanding valuation. The company does not need a dramatic quarterly beat; it needs to demonstrate that 3%–4% organic growth and 100 basis points of full-year margin expansion remain credible despite elevated costs and a pressured consumer.
The highest-quality result would combine approximately 3% or better organic growth, positive volume, margin upside, continued TOUCHLAND momentum and firmer confidence in second-half earnings acceleration. The biggest risk is that Q1’s strength proves difficult to sustain just as transportation, commodity and acquisition-related costs weigh on profitability.